glp 1 enzyme PDB-101: Molecule of the Month: GLP-1 Receptor Agonists Glucagon-like Peptide-1 (GLP-1), Active Form

This once-weekly subcutaneous injectable drug, which mimics the natural GLP-1 hormone and activates GLP-1 receptors in the gastrointestinal tract, pancreas, and brain in response to food, 7 was initially used solely for diabetes treatment

doi: 10.3389/fphar.2026.1775366 Received 31 December 2025 Revised 24 February 2026 Accepted 25 February 2026 Published 25 March 2026 Volume 17 - 2026 Edited by Roberta Imperatore, University of Sannio, Italy Reviewed by Chongjun Zhao, Beijing University of Chinese Medicines, China Marta Mastrogiovanni, Albert Einstein College of Medicine, United States Tamer A

In a randomized controlled trial (RCT), Moaddel et al

The author and publisher disclaim any liability or loss in connection with the information provided here

10.1002/jbt.22049 285 ZhaoH.MingT.TangS.RenS.YangH.LiuM.et al (2022)